4 results  1 of 1 

1 Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy
Kyunghwan Oh, Kee Don Choi, Hyeong Ryul Kim, Tae Sun Shim, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park
Clin Endosc.2023;56(2):239-244.   Published online 2021 December 21     DOI: http://dx.doi.org/10.5946/ce.2021.215
      
2 Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study
Seung Yong Shin, Soo Jung Park, Young Kim, Jong Pil Im, Hyo Jong Kim, Kang-Moon Lee, Ji Won Kim, Sung-Ae Jung, Jun Lee, Sang-Bum Kang, Sung Jae Shin, Eun Sun Kim, You Sun Kim, Tae Oh Kim, Hyun-Soo Kim, Dong Il Park, Hyung Kil Kim, Eun Soo Kim, Young-Ho Kim, Do Hyun Kim, Dennis Teng, Jong-Hwa Kim, Wonyong Kim, Chang Hwan Choi
Intest Res.2022;20(3):350-360.   Published online 2021 July 23     DOI: http://dx.doi.org/10.5217/ir.2021.00049
      
3 Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy
Jihye Kim, Jong Pil Im, Jae-Joon Yim, Chang Kyun Lee, Dong Il Park, Chang Soo Eun, Sung-Ae Jung, Jeong Eun Shin, Kang-Moon Lee, Jae Hee Cheon
Korean J Gastroenterol.2020;75(1):29-38.   Published online 2020 January 29     DOI: http://dx.doi.org/10.4166/kjg.2020.75.1.29
      
4 Review of Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis
Jung-Soo Song
J Korean Rheum Assoc.2007;14(1):1-14.   Published online 2007 March 23     DOI: http://dx.doi.org/10.4078/jkra.2007.14.1.1
   

 1 of 1